Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...
Source And Potency Of Stem Cells01:27

Source And Potency Of Stem Cells

Stem cells are undifferentiated cells with extensive self-renewal properties that help them maintain their population during the fetal and adult stages of life. They can specialize in all cell types of the human body. However, their differential potential may vary and can be classified into five types. Stem cells can be (1) Totipotent, (2) Pluripotent, (3) Multipotent, (4) Oligopotent, and (5) Unipotent. Each stem cell has a specific origin; the fertilized egg or zygote is a totipotent cell and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Acellular Normothermic Machine Perfusion Does not Exacerbate Acute Rejection in Rodent Vascularized Composite Allografts.

Transplantation direct·2026
Same author

Protein Diffusion in Electroporation-Based Biopsy: Quantifying Protein Transport From Human Skin for Skin Liquid Sampling With Electroporation.

Biotechnology and bioengineering·2026
Same author

The organ-on-a-chip mirage: Animal replacement, plastic channels, and plastic claims: <i>The False Narrative Behind the War on Animal Research</i>.

Innovation and emerging technologies·2026
Same author

Chronopharmacology of AAV gene therapy in mice.

microPublication biology·2025
Same author

Mechanotyping of Organoids for Assessing Drug-Induced Injuries.

Advanced materials (Deerfield Beach, Fla.)·2025
Same author

Correction: Comparing two extracellular additives to facilitate extended storage of red blood cells in a supercooled state.

Frontiers in physiology·2025
Same journal

Mapping the 3D Chromosome Organization of a Biosynthetic Gene Cluster by Capture Hi-C (CHi-C).

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Mapping the 3D Chromosome Organization of Streptomyces by Hi-C.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

CUT&Tag Epigenomic Profiling of Biosynthetic Gene Clusters in Arabidopsis thaliana.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Rhizobium rhizogenes-Mediated Hairy Root Transformation Protocol for Lotus japonicus and Other Legumes.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Characterization of Bioactive Saponins from Sea Cucumbers.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Methods for Functional Validation of Terpenoid Metabolic Clusters in Nicotiana benthamiana and Aspergillus oryzae.

Methods in molecular biology (Clifton, N.J.)·2026
See all related articles

Related Experiment Video

Updated: Jun 8, 2026

Assessment of the Immunomodulatory Properties of Human Mesenchymal Stem Cells (MSCs)
06:20

Assessment of the Immunomodulatory Properties of Human Mesenchymal Stem Cells (MSCs)

Published on: December 24, 2015

A mesenchymal stem cell potency assay.

Joy Jiao1, Jack M Milwid, Martin L Yarmush

  • 1Center for Engineering in Medicine and Surgical Services, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Methods in Molecular Biology (Clifton, N.J.)
|October 14, 2010
PubMed
Summary
This summary is machine-generated.

Mesenchymal stem cells (MSCs) enhance survival and reduce inflammation by releasing factors. An in vitro model now measures Interleukin-10 (IL-10) release, aiding in assessing MSC potency for treating inflammatory diseases.

Related Experiment Videos

Last Updated: Jun 8, 2026

Assessment of the Immunomodulatory Properties of Human Mesenchymal Stem Cells (MSCs)
06:20

Assessment of the Immunomodulatory Properties of Human Mesenchymal Stem Cells (MSCs)

Published on: December 24, 2015

Area of Science:

  • Immunology
  • Regenerative Medicine
  • Cell Biology

Background:

  • Mesenchymal stem cells (MSCs) demonstrate immunomodulatory capabilities, successfully treating inflammatory diseases in preclinical models.
  • Paracrine signaling, the release of bioactive factors, is increasingly recognized as the primary mechanism behind MSC therapeutic effects.
  • MSC-secreted factors promote survival, reduce inflammation, and activate endogenous repair, leading to disease resolution in models of organ failure.

Purpose of the Study:

  • To develop an in vitro assay that models Interleukin-10 (IL-10) release from blood cells, mirroring in vivo observations.
  • To establish a tool for evaluating the potency of Mesenchymal stem cell-conditioned medium (MSC-CM) and Mesenchymal stem cell-lysate (MSC-Ly).
  • To characterize the interactions between MSC-derived products and target blood cells.

Main Methods:

  • Development of an in vitro system using blood cells to measure IL-10 release.
  • Administration of MSC-conditioned medium (MSC-CM) and MSC-lysate (MSC-Ly) in the in vitro model.
  • Quantification of IL-10 as a marker of cellular response and therapeutic potency.

Main Results:

  • The in vitro model successfully recapitulates the in vivo observation of increased IL-10 release following MSC-derived product administration.
  • The assay demonstrates the ability to analyze the potency of MSC-CM and MSC-Ly in stimulating IL-10 production.
  • Characterization of MSC-CM and MSC-Ly interactions with blood cells is facilitated by this model.

Conclusions:

  • An in vitro assay for IL-10 release from blood cells provides a reliable method to assess MSC therapeutic potential.
  • This model aids in understanding the paracrine mechanisms of MSCs in modulating immune responses.
  • The developed assay is valuable for quality control and characterization of MSC-based therapies for inflammatory conditions.